Home > Boards > US Listed > Biotechs > Bio-Path Holdings Inc. (BPTH)

Wow!!The recent PPS drop has been substantial.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SJSTOCKSHARK Member Profile
 
Followed By 11
Posts 1,589
Boards Moderated 1
Alias Born 09/19/06
160x600 placeholder
Bio-Path Holdings Announces $8.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 11/21/2019 11:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/21/2019 8:21:07 AM
Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002 GlobeNewswire Inc. - 11/21/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2019 7:08:27 AM
Bio-Path Holdings Reports Third Quarter 2019 Financial Results GlobeNewswire Inc. - 11/15/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:25:09 PM
Bio-Path Holdings to Announce Third Quarter 2019 Financial Results on November 15, 2019 GlobeNewswire Inc. - 11/8/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/1/2019 4:49:22 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/1/2019 4:46:18 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/22/2019 5:06:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 4:24:51 PM
Bio-Path Holdings Appoints Martina Molsbergen to Board of Directors GlobeNewswire Inc. - 10/15/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/25/2019 5:17:26 PM
Bio-Path Updates Intellectual Property Portfolio with Addition of Recently Issued Second Platform Technology Patent GlobeNewswire Inc. - 9/25/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2019 4:07:11 PM
Bio-Path Holdings to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire Inc. - 9/3/2019 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2019 6:02:06 AM
Bio-Path Announces Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia GlobeNewswire Inc. - 8/26/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/15/2019 7:06:51 AM
Bio-Path Holdings Reports Second Quarter 2019 Financial Results GlobeNewswire Inc. - 8/15/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 4:20:01 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/6/2019 5:07:29 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/6/2019 5:05:06 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 6/6/2019 6:01:49 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 4:31:59 PM
SJSTOCKSHARK   Wednesday, 10/02/19 06:46:38 PM
Re: None
Post # of 6212 
Wow!!

The recent PPS drop has been substantial.

Was the rise to $70 simply to set up a short play?

If so, I suspect we will see two dollars before $20.

Our analysts stock price predictions for some reason seem to herald price declines rather than their projected valuations. $28 a share seems like a long time ago.

I hope the company raised some money before the stock entered the single digits. If not, the dilution will be substantial when they need cash.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist